- Home
- Companies
- canada quebec
- disease progression
Show results for
Refine by
Disease Progression Suppliers Serving Quebec
94 companies found
based inDreieich, GERMANY
Biotest - innovation in haematology, clinical immunology and intensive care medicine. Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and ...
IgG Next Generation is a new development of a polyvalent immunglobulin (IVIG) for the treatment of immunedeficiencies and auto immune diseases. IgG Next Generation is being manufactured with a new and innovative production process and will be the ...
based inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
based inWürzburg, GERMANY
Toleris Biotherapeutics GmbH is a biotechnology company based in Würzburg, Germany. The company specializes in the development of innovative biotherapeutic solutions aiming to advance the field of medicine through cutting-edge scientific research. ...
By leveraging optimized soluble versions of the non-classical MHC Ib molecule HLA-G, AIM Biologicals can accumulate in lymph nodes to induce regulatory CD8+ T cells that protect tissues presenting autoantigens attacked in autoimmune ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Alovudine (3'-Fluoro-3'-deoxythymidine) is a mtDNA synthesis inhibitor and a marker of DNA synthesis. Alovudine is less susceptible to inflammatory changes than 18F-Fluorodeoxyglucose (FDG) and thus is a better biomarker in pancreatic cancer. ...
based inSydney, AUSTRALIA
Uscom Limited (UCM) is an Australian founded, ASX listed innovative medical technology company specialising in development and global marketing of premium non-invasive cardiovascular and pulmonary medical devices. Uscom has a mission to demonstrate ...
based inYokohama-shi, JAPAN
DNAFORM is the development-type company which aims at the “Development of Human Health Care”, “Modernization of Hospitals and Social Health Care” and “Contribution to realization of Smart Medical City”. For this purpose, the development of the ...
DNAFOM CAGE library preparation services ensure all your bases are covered providing an end-to-end unique transcriptome solution including library construction, sequencing on the Illumina HiSeq platforms and comprehensive data analysis. CAGE, Cap ...
based inLa Ciotat, FRANCE
At Olea Medical, one overriding value rises above all others: preserve live. Our mission is to create innovative imaging solutions that serve human beings by delivering improved diagnostic information for better patient care. Olea Medical has built ...
Our breakthrough neuroimaging tools seamlessly integrate into your daily clinical CT & MRI workflows to assist you in every step of your decision-making in pre- and post-treatment ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Pelabresib (CPI-0610) is an investigational selective small-molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes ...
based inNew York, NEW YORK (USA)
On a mission to unlock the power of data to improve health. Transactional health data has long been the foundation of healthcare analytics. But alone, it has serious analytical limitations — on prognoses, trials, outcomes, and commercial education. ...
Generate powerful outcomes insights from closed medical and pharmacy claims integrated with harmonized lab data.Empower outcomes studies with a full view of patient activity including lab results. Outcomes research is used by life science ...
based inManassas, VIRGINIA (USA)
Notal Vision is the first diagnostic services company to extend eye disease management from the clinic to the home and improve vision outcomes. By applying artificial intelligence (AI)-driven data interpretation to the unprecedented high volumes of ...
A home-based monitoring program supporting earlier detection of wet AMD in intermediate dry AMD patients. FDA-Cleared and Covered by Medicare and Most Private Insurance. The progression from dry Age-related Macular Degeneration (AMD) to wet AMD can ...
based inOklahoma City, OKLAHOMA (USA)
By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...
based inNorth Brunswick, NEW JERSEY (USA)
Ascendia Pharmaceuticals specializes in the invention and development of specialty pharmaceutical products and novel formulation technologies. We provide formulation, analytical, and manufacturing services to pharmaceutical companies, working ...
based inKiel, GERMANY
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug ...
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the ...
based inRegensburg, GERMANY
numares is an innovative diagnostics company. We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that could not be addressed by single biomarker-based ...
Common cancers with established benefit of early diagnosis but for which there are no sensitive or specific tests are prostate, bladder and liver cancer1. Expensive imaging procedures are routinely required in clinical practice for diagnosis or to ...
based inTirat Carmel, ISRAEL
Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time. MeMed’s interdisciplinary ...
Some infections resolve quickly, while others lead to severe immune dysregulation, respiratory failure and death. Distinguishing between the two is challenging.MeMed COVID-19 Severity builds on an extensive body of evidence supporting the role of ...
based inMechelen, BELGIUM
Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...
based inImmeuble l’Etendard, FRANCE
Carmat will provide cardiologists with innovative technologies that save lives and improve the quality of life for patients with advanced heart failure. Become the primary alternative to heart transplants with the implementation of our Total ...
based inParis, FRANCE
Founded in 2011, Endodiag is specialized in the development of products and services aimed at improving the diagnosis of endometriosis, a complex and poorly known disease, affecting yet 10% of women of reproductive age (over 180 million patients ...
Endodiag together with several expert gynecologists has developed EndoGram, a 10-biomarker test based on the analysis of biopsies taken during surgery. Thanks to a proprietary algorithm combining other patient clinical factors, EndoGram provides for ...
based inDepew, NEW YORK (USA)
Reichert Technologies, based in Buffalo, New York, is a global leader in designing, engineering, and manufacturing high-quality diagnostic devices and equipment for ophthalmologists, optometrists, opticians, and retail eye centers. Inventor of ...
based inLondon, UNITED KINGDOM
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. Colostrinin™ is promoted as having utility as a support for healthy brain ageing and cognition. ...